Opus Genetics (IRD) Short-term Investments (2010 - 2025)
Opus Genetics (IRD) posted quarterly Short-term Investments of $1000.0 for Q1 2025, down 80.0% year-over-year from $5000.0 in Q1 2024, and down 50.0% quarter-over-quarter from $2000.0 in Q4 2024.
Powered by 
Analysis
Opus Genetics (IRD) Short-term Investments (2010 - 2025) Analysis & Trends
Opus Genetics (IRD) has reported Short-term Investments for 15 consecutive years, with $1000.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Short-term Investments fell 80.0% year-over-year to $1000.0; the TTM figure through Mar 2025 stood at $1000.0 (down 80.0% YoY), while the FY2024 annual figure was $2000.0, down 86.67% from the prior year.
- Short-term Investments slipped to $1000.0 in Q1 2025 per IRD's latest filing, from $2000.0 in the prior quarter.
- Across five years, Short-term Investments topped out at $383000.0 in Q3 2021 and bottomed at $1000.0 in Q1 2025.
- Historically, Short-term Investments has averaged $73266.7 across 5 years, with a median of $22000.0 in 2023.
- On a YoY basis, Short-term Investments climbed as much as 69.39% in 2023 and fell as far as 89.11% in 2023.
- Opus Genetics' Short-term Investments stood at $219000.0 in 2021, then sank by 77.63% to $49000.0 in 2022, then plunged by 69.39% to $15000.0 in 2023, then slumped by 86.67% to $2000.0 in 2024, then slumped by 50.0% to $1000.0 in 2025.
- Business Quant data shows IRD's Short-term Investments at $1000.0 in Q1 2025, $2000.0 in Q4 2024, and $3000.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Opus Genetics | 446.86 Mn | 358.05 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Sep 30, 2023 | 11,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 49,000.00 |
| Sep 30, 2022 | 101,000.00 |
| Jun 30, 2022 | 126,000.00 |
| Mar 31, 2022 | 135,000.00 |
| Dec 31, 2021 | 219,000.00 |
| Sep 30, 2021 | 383,000.00 |
| Dec 31, 2019 | 3.00 Mn |
| Sep 30, 2019 | 5.98 Mn |
| Jun 30, 2019 | 8.95 Mn |
| Mar 31, 2019 | 11.89 Mn |
| Dec 31, 2018 | 5.98 Mn |